Patient Preference Studies: Patient Experience as Decision-Grade Evidence
Discover how patient preference studies use qualitative and quantitative methods to generate decision-Grade Evidence across development and commercialization.
Home > Education Hub > Articles
Articles
FDA Initiatives and Programs to Support Development of Treatments for Rare Diseases in 2026
Discover FDA programs in 2026 that foster rare disease drug development, offering guidance, funding, and regulatory support for innovators.
How to Develop Global Clinical Evidence Strategies for Regulatory Success in Medtech
Discover how a strategically planned clinical evidence generation strategy can support global device approval, maximize evidence value, and prepare for international expansion.
The Distinct Characteristics of Product Development in Myasthenia Gravis
Explore how patient-reported outcome complexity, subtype-stratified trials, and AI are shaping product development in myasthenia gravis.
How Pharma and Medtech Convergence Is Changing DDS Partner Selection in 2026
Learn how pharma and medtech convergence is reshaping drug delivery system partner selection, from combination products and regulatory readiness to integrated execution.
Preparing Rare Disease Manufacturers for JCA: The Role of Early Stakeholder Engagement
Discover how stakeholder engagement helps rare disease manufacturers prepare for JCA and how to apply stakeholder management best practices in the JCA context.